Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20243740Phase 3Completed
A Phase 3 trial of landiolol in Atrial fibrillation (AFib), atrial flutter (AFL), sinus tachycardia (ST), tachyarrhythmia, sponsored by Hainan Herui Pharmaceutical. Started Oct 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20243740.